Share on LinkedInShare on LinkedIn

ARTICLE · 05 DECEMBER 2021

Patent Case Summaries | Week Ending November 26, 2021

A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial and Appeal Board.

United StatesIntellectual Property

A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial and Appeal Board.


Indivior UK Limited v. Dr. Reddy's Laboratories S.A., et al., Nos. 2020-2073, -2142 (Fed. Cir. (PTAB) Nov. 24, 2021). Opinion by Lourie, joined by Dyk. Opinion concurring in part and dissenting in part by Linn.

Dr. Reddy's initiated an IPR challenging claims 1-5 and 7-14 of a patent owned by Indivior relating to orally dissolvable films containing therapeutic agents. Claim 8 requires a specific polymer weight percentage, and the other claims require a range of polymer weight percentages. Dr. Reddy's argued that the polymer weight percentage limitations lacked written description support in a parent application and thus were not entitled to the benefit of the parent application's filing date. Indivior disagreed and argued that the parent application

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from